Published Mar 20, 2025

Labshares x BYTE51: A Game-Changing Partnership to Navigate Fundraising

Labshares News

Fundraising is one of the biggest challenges for startups, and at Labshares, we’re committed to providing real, tangible support where our member companies need it most. That’s why we’re excited to announce our partnership with BYTE51—making Labshares the first shared lab space to offer access to a cutting-edge funding intelligence platform powered by $650B+ in Science & VC funding data.

Why Fundraising Intelligence Matters

For life sciences and biotech startups, securing the right funding at the right time can mean the difference between success and stagnation. The venture capital landscape is constantly shifting, making it difficult for early-stage companies to track investors, understand competitive dynamics, and anticipate market trends.

 

Through our exclusive partnership with BYTE51data, Labshares members now have access to a powerful, data-driven platform designed to streamline he fundraising process and empower startups with actionable intelligence.

 

What Does BYTE51 Offer?

At our recent Lunch & Learn, the BYTE51 team demonstrated how their platform helps startups:

·      Identify the right investors – Use advanced screening tools to find venture capitalists, angel investors, and funding sources that align with your stage, industry, and focus.

·      Stay ahead of industry trends – Set up real-time alerts to track funding rounds, partnership announcements, and key developments that impact your sector.

·      Map the competitive landscape – Gain in-depth insights into your competitors, their funding history, and the clinical stages of their products to inform your strategic decisions.

An Exclusive Benefit for Labshares Members

Unlike any other shared lab space, Labshares members receive a free seat on BYTE51’s platform. This exclusive benefit gives our startups an unmatched edge in navigating today’s fundraising environment.

 

At Labshares, we’re always looking for ways to provide more than just lab space—we’re building a community that supports startup success. Whether it’s through strategic partnerships, networking opportunities, or access to powerful resources like BYTE51 we’re committed to helping our companies grow.

Reach out to learn more about this exclusive benefit!

Related or similar articles

October 9, 2024

Explore Labshares' Latest High-Tech Equipment Advancements

Labshares News
March 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

First in vivo validation of KLRG1 as a new cancer immunotherapy target
Member News
August 8, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News